JPS62281956A - Blood component removing apparatus - Google Patents

Blood component removing apparatus

Info

Publication number
JPS62281956A
JPS62281956A JP61124454A JP12445486A JPS62281956A JP S62281956 A JPS62281956 A JP S62281956A JP 61124454 A JP61124454 A JP 61124454A JP 12445486 A JP12445486 A JP 12445486A JP S62281956 A JPS62281956 A JP S62281956A
Authority
JP
Japan
Prior art keywords
pressure
blood
plasma
pump
flow rate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP61124454A
Other languages
Japanese (ja)
Other versions
JPH0657255B2 (en
Inventor
邦治 鬼村
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yokogawa Electric Corp
Original Assignee
Yokogawa Electric Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yokogawa Electric Corp filed Critical Yokogawa Electric Corp
Priority to JP61124454A priority Critical patent/JPH0657255B2/en
Publication of JPS62281956A publication Critical patent/JPS62281956A/en
Publication of JPH0657255B2 publication Critical patent/JPH0657255B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/34Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
    • A61M1/3472Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration with treatment of the filtrate
    • A61M1/3486Biological, chemical treatment, e.g. chemical precipitation; treatment by absorbents

Landscapes

  • Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Vascular Medicine (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • External Artificial Organs (AREA)

Abstract

(57)【要約】本公報は電子出願前の出願データであるた
め要約のデータは記録されません。
(57) [Summary] This bulletin contains application data before electronic filing, so abstract data is not recorded.

Description

【発明の詳細な説明】 〈産業上の利用分野〉 本発明は、血液に含まれているコレステロール等の有害
成分を選択的に除去する血中成分除去装置に関する。
DETAILED DESCRIPTION OF THE INVENTION <Industrial Application Field> The present invention relates to a blood component removal device that selectively removes harmful components such as cholesterol contained in blood.

〈従来の技術〉 上述のような血中成分除去装置として、例えば特開昭5
9−197255号公報に開示されている除去装置が公
知となっている。この除去装置は、供血者から採取した
血液を送液する第1ポンプと、該血液を血漿と血球部分
に分離する血漿分離部と、該血漿に含まれている特定成
分(例えばリポ蛋白等)を選択的に除去する選択的除去
部と、該選択的除去部に前記血漿分離部で分離された血
漿を送液する@2ポンプと、前記血漿分離部で分離され
た血球部分に前記特定成分が選択的に除去された血漿を
混合させる混合部とを設け、上記第1および第2のポン
プを手動操作でスピードコントロールして、血液に含ま
れている前記特定成分を除去するようにしていた。
<Prior art> As a blood component removal device as described above, for example, Japanese Patent Application Laid-open No. 5
A removal device disclosed in Japanese Patent No. 9-197255 is known. This removal device includes a first pump that sends blood collected from a donor, a plasma separation section that separates the blood into plasma and blood cells, and specific components (such as lipoproteins) contained in the plasma. a selective removal section that selectively removes the plasma; a @2 pump that sends the plasma separated in the plasma separation section to the selective removal section; A mixing unit is provided to mix the plasma from which blood has been selectively removed, and the speed of the first and second pumps is manually controlled to remove the specific components contained in the blood. .

然し乍ら、上記従来例においては、第1および第2のポ
ンプを手動操作でスピードコントロールするため、迅速
性に欠けるうえ、供血者の容態lに対応させた血流確保
ができず安全上も問題があった6 〈発明が解決しようとする問題点〉 本発明は上述のような状況に鑑みてなされたものであり
、その目的は、供血者の容態に適合した血流を1保しな
がら安全かつ迅速に、血液中の有害成分を選択的に除去
できる血中成分除去器を提供することにある。
However, in the above-mentioned conventional example, the speed of the first and second pumps is controlled manually, which not only lacks speed but also poses a safety problem as it is not possible to ensure blood flow in accordance with the donor's condition. <Problems to be solved by the invention> The present invention was made in view of the above-mentioned situation, and its purpose is to maintain blood flow that is compatible with the condition of the blood donor while safely and To provide a blood component remover capable of quickly and selectively removing harmful components from blood.

く問題点を解決するための手段〉 上述のような問題点を解決する本発明の特徴は、血中成
分除去装置において、採取した血液を送液する第1ポン
プと該血液から分離した血漿を送液する第2ポンプとを
、複数個の圧力計で検出した圧力信号に基ずく演算で求
めた各駆動信号で送液流量制御を行なうようにしたこと
にある。
Means for Solving the Problems> A feature of the present invention that solves the above-mentioned problems is that in a blood component removal device, a first pump for delivering collected blood and a first pump for transporting plasma separated from the blood are provided. The liquid feeding flow rate of the second pump, which feeds the liquid, is controlled using drive signals calculated based on pressure signals detected by a plurality of pressure gauges.

〈実施例〉 以下、本発明について図を用いて詳細に説明する。図は
本発明実施例の構成説明図であり、図中、laは供血者
の腕等(図示せず)から血液を採取する採血部、1bは
供血者の腕等(図示せず)K血液を戻す返血部、2a〜
2dは血液(又は血漿)チャンバー、33〜3eは第1
〜第5の圧力計、4aは血液を送液する第1ポンプ、4
bは血漿を送液する第2ポンプ、5は例えばチューブ状
の膜5aKよって内部が内室5bと外室5cに仕切られ
ると共に核内室5bには流入口5dと流出口5eが設け
られ外室5cには蒐入去器、7は混合部、8は第1〜第
5の圧力計3a〜3eから圧力信号81〜S5を受けて
所定の演算処理を行ない該演算結果に基いたモータ駆動
信号ml 、 m2を夫々第1および第2ポンプ4a、
4bK送出する制御部である。
<Example> Hereinafter, the present invention will be described in detail using the drawings. The figure is an explanatory diagram of the configuration of an embodiment of the present invention. In the figure, la is a blood collection part that collects blood from the donor's arm, etc. (not shown), and 1b is K blood from the donor's arm, etc. (not shown). Blood return section, 2a~
2d is the blood (or plasma) chamber, 33 to 3e are the first
~Fifth pressure gauge, 4a is the first pump that pumps blood, 4
Reference numeral b denotes a second pump for pumping plasma; 5, the interior is partitioned into an inner chamber 5b and an outer chamber 5c by, for example, a tube-shaped membrane 5aK; the inner nuclear chamber 5b is provided with an inlet 5d and an outlet 5e; In the chamber 5c, there is a sowing device, 7 is a mixing section, and 8 is a motor drive which receives pressure signals 81 to S5 from the first to fifth pressure gauges 3a to 3e, performs predetermined calculation processing, and drives a motor based on the calculation results. The signals ml and m2 are transmitted to the first and second pumps 4a, respectively.
This is a control unit that sends out 4bK.

このような構成からなる本発明の実施例において、最初
、あらかじめ制御部8に設定された設定値に灼応するモ
ータ駆動信号rn1 、 ff12が制御部8がら第1
および第2のポンプ4a、 4bに送出され、該駆動信
号m1+ m2に従って第1および第2のポンプ4a、
 4bが駆動している。この第1ポンプ4aの駆動によ
り、供血者の腕等(図示せず)から採血部1aを介して
血液が採取され、該血液が、血液チャンバー2a、第1
ポンプ4a、および血液チャンバー2bを経て、血漿分
離器5に至る。該血漿分離器5において、血液中の血漿
が膜5aを介して外室5cに導びかれ残りの血球部分が
、流出口5eから混合部7に導かれる。また、外室5C
内の血漿は、第2ポンプ4bの駆動により、流量ロ5g
、第2ポンプ4b、 および血液チャンバー20を経て
、選択的除去器6に至る。該除去器6において、血漿中
の有害成分(例えばフレステロール)が上記吸着剤に吸
着されて除去され、該有害成分が除去された血漿が、流
出口6bから混合部7に導びかれる。該血漿は、混合部
7において、血漿分離器5の流出口5eから導びかれて
いる上記血球成分と混合し、血液チャンバー2Cを経て
返血部1bから供血者の腕等に返血される。
In the embodiment of the present invention having such a configuration, first, the motor drive signals rn1 and ff12 corresponding to the set values set in advance in the control unit 8 are sent to the first
and the second pumps 4a, 4b according to the drive signals m1+m2.
4b is being driven. By driving the first pump 4a, blood is collected from the donor's arm or the like (not shown) through the blood collection section 1a, and the blood is transferred to the blood chamber 2a and the first pump.
It reaches the plasma separator 5 via the pump 4a and the blood chamber 2b. In the plasma separator 5, plasma in the blood is led to the outer chamber 5c via the membrane 5a, and the remaining blood cells are led to the mixing section 7 from the outlet 5e. Also, outside room 5C
The plasma in
, the second pump 4b, and the blood chamber 20 to the selective remover 6. In the remover 6, harmful components (for example, fresterol) in the plasma are adsorbed by the adsorbent and removed, and the plasma from which the harmful components have been removed is led to the mixing section 7 from the outlet 6b. The plasma is mixed in the mixing section 7 with the blood cell components introduced from the outlet 5e of the plasma separator 5, and is returned to the donor's arm or the like from the blood return section 1b via the blood chamber 2C. .

一方、血液チャンバー2a内の血液圧力(Pl)が第1
圧力計3aで検出され、該検出信号が上記圧力信号S1
として制御部8に入力され監視さnる。供血者の容態が
悪化する等して供血者の血圧が低下すると、該血圧低下
は第1圧力計33で検出され、該検出信号に応じて制御
部8の指令で第1ポンプ4aの送液流量が低下させられ
る。このため、供血者の腕等から採血部1aを介して採
取される血液の量が減少し、供血者の安全を保つことが
できる。
On the other hand, the blood pressure (Pl) in the blood chamber 2a is
It is detected by the pressure gauge 3a, and the detection signal is the pressure signal S1.
The signal is input to the control unit 8 and monitored. When the donor's blood pressure decreases due to deterioration of the donor's condition, etc., the decrease in blood pressure is detected by the first pressure gauge 33, and the first pump 4a is activated to send fluid according to a command from the control unit 8 in accordance with the detection signal. Flow rate is reduced. Therefore, the amount of blood collected from the donor's arm or the like via the blood collection unit 1a is reduced, and the safety of the blood donor can be maintained.

また、供血者の容態が回復して血圧が元通りKなると、
該血圧が第1圧力計33で検出され、該検出信号S1に
応じて出力される制御部8の指令(原動信号mx )で
第1ポンプ4aの送液itが増加させられ、定常状態に
至る。ところで、血漿分1JiI器5に導びかれた血液
は、摸5aKよって血漿と血球成分に分離されるが、該
1(li5aが目詰りをおこしたりして血漿分離器5に
おける圧損が上昇することがある。この場合、血漿分離
器S内に血液を供給し続けると、膜5aが破損する等危
険な状態に陥いるおそれがある。このため、第2圧力計
3bと第3圧力計3Cで検出された圧力信号S2−83
に基いて制御部8で(p2−p3)の演算が行なわれ該
演算値が一定圧力値C1を超えず且つ第3圧力計3cで
検出される圧力が一定圧力値0□(これらの値01.0
2はともに制御部8にあらかじめ設定されている)を超
えないように、制御部8によって第1ポンプ4aの送液
流量が制御される。、また、第2ポンプ4bは次の(イ
)〜(!つの条件を満足するように制御部80指令(即
ち、駆動信号m2 )によってその送液流量が制御され
る。
Also, when the donor's condition recovers and his blood pressure returns to normal,
The blood pressure is detected by the first pressure gauge 33, and the liquid delivery IT of the first pump 4a is increased by the command (driving signal mx) of the control unit 8 output in response to the detection signal S1, and a steady state is reached. . By the way, the blood led to the plasma separator 5 is separated into plasma and blood cell components by the plasma separator 5, but the pressure drop in the plasma separator 5 may increase due to clogging of the plasma separator 5a. In this case, if blood is continued to be supplied into the plasma separator S, there is a risk that the membrane 5a may be damaged or other dangerous situations may occur.For this reason, the second pressure gauge 3b and the third pressure gauge 3C may Detected pressure signal S2-83
The control unit 8 calculates (p2-p3) based on , and the calculated value does not exceed the constant pressure value C1, and the pressure detected by the third pressure gauge 3c reaches the constant pressure value 0□ (these values 01 .0
2 are preset in the control unit 8), the control unit 8 controls the liquid feeding flow rate of the first pump 4a. In addition, the liquid feeding flow rate of the second pump 4b is controlled by the control unit 80 command (i.e., drive signal m2) so as to satisfy the following conditions (a) to (!).

0) 制御部8がら上記第1ポンプ4aに送出される駆
動信号m1に基いて制御部8内で算出される血流量Q2
が下式(1〉を満足するように制御部8が第2ポンプ4
bの送液流量を制御する。
0) Blood flow rate Q2 calculated within the control unit 8 based on the drive signal m1 sent from the control unit 8 to the first pump 4a.
The control unit 8 controls the second pump 4 so that the following formula (1) is satisfied.
Control the liquid feeding flow rate of b.

Q:2≦kQl              (1)こ
のような流量制御により、血漿分離55内で血漿をとり
すぎて膜5aが目詰抄するのを防止できるようになる。
Q: 2≦kQl (1) Such flow rate control makes it possible to prevent the membrane 5a from being clogged due to too much plasma being taken in the plasma separation 55.

(ロ) 第2.第3.および第5の圧力計3b、3c、
3eで検出される圧力P2.P3.およびP5の間に下
式(2)が成立するように、制御部8が第2ポンプ4b
の送液流量を制御する。
(b) Second. Third. and fifth pressure gauges 3b, 3c,
Pressure P2 detected at 3e. P3. The control unit 8 controls the second pump 4b so that the following formula (2) holds between P5 and P5.
Controls the liquid flow rate.

このような流量制御により、上記膜5aの細孔内に血球
成分が入って破壊されるという溶血現儂が起こることを
防止できるようになる。尚、上記03は例えば50 (
rrrnHg )である。
Such flow rate control makes it possible to prevent hemolysis, in which blood cell components enter the pores of the membrane 5a and are destroyed. Note that the above 03 is, for example, 50 (
rrrnHg).

(ハ) 第3および第4の圧力計3C+ 3dで検出さ
れる圧力P3.P4の差(P4−P3)が、制御部8内
にあらかじめ設定されている一定圧力値04を超えない
よう、即ち下式(3)が成立するように制御部8が第2
ポンプ4bの流量を制御する。
(c) Pressure P3 detected by the third and fourth pressure gauges 3C+ 3d. The control unit 8 controls the second
Controls the flow rate of the pump 4b.

(p4−p3)≦04(3) このような流量制御により、選択的除去器6に流入する
血漿の圧力が過大とな抄、選択的除去器6内の吸着剤性
能が低下したりする悪影響が生ずるのを未然に防止でき
るようになる。
(p4-p3)≦04 (3) Such flow rate control causes negative effects such as excessive pressure of plasma flowing into the selective remover 6 and deterioration of adsorbent performance in the selective remover 6. can be prevented from occurring.

〈発明の効果〉 以上詳しく説明したような本発明によれば、第1圧力計
33で血圧を監視し、供血者の容態が悪化したような場
合には制御部8の指令で第1ポンプ4aの流量を低下さ
せるような構成であるため、供血者の容態に適合した血
液採取ができる利点がある。また、第2〜第5の圧力計
3b〜3eで検出される圧力信号82〜S5に基いて所
定の演算を行ない最適条件となるよう第2ポンプ4bの
流量制御を行なう構成であるため、血漿中の有害成分除
去を安全かつ効率よく行なえる利点もある。
<Effects of the Invention> According to the present invention as described in detail above, the blood pressure is monitored by the first pressure gauge 33, and when the donor's condition worsens, the first pump 4a is activated by a command from the control unit 8. Since the structure is such that the flow rate of blood is reduced, there is an advantage that blood can be collected in accordance with the condition of the blood donor. In addition, since the configuration is configured to perform predetermined calculations based on the pressure signals 82 to S5 detected by the second to fifth pressure gauges 3b to 3e and control the flow rate of the second pump 4b to achieve the optimum condition, plasma Another advantage is that harmful components inside can be removed safely and efficiently.

【図面の簡単な説明】[Brief explanation of the drawing]

図は本発明実施例の構成説明図である。 la・・・採血部、1b・・・返血部、2a〜2d・・
・チャンバー、38〜3e・・・圧力計、4a、 4b
・・・ポンプ、5・・・血漿分離器、6・・・選択的除
去器、7・・・混合部、8・・・制御部。 ど1、\
The figure is a configuration explanatory diagram of an embodiment of the present invention. la...Blood collection section, 1b...Blood return section, 2a-2d...
・Chamber, 38-3e...Pressure gauge, 4a, 4b
Pump, 5 Plasma separator, 6 Selective remover, 7 Mixing section, 8 Control section. Do1,\

Claims (3)

【特許請求の範囲】[Claims] (1)供血者から採取した血液を送液する第1ポンプと
、内部が膜によって内室と外室に仕切られており該内室
内に前記血液が導びかれると血漿と血球部分に分離する
血漿分離器と、前記外室内の血漿を送液する第2ポンプ
と、吸着剤が充填されており前記血漿が導入されると該
血漿中の有害成分を選択的に除去する選択的除去器と、
前記第1ポンプの上流側圧力P_1を検出する第1圧力
計と、前記血漿分離器の入口側圧力P_2を検出する第
2圧力計と、前記供血者へ戻す血液の圧力P_3を検出
する第3圧力計と、前記選択的除去器の入口側圧力P_
4を検出する第4圧力計と、前記血漿分離器の外室内圧
力P_5を検出する第5圧力計と、これら第1〜第5の
圧力計からの検出信号を受けて所定の演算を行ない前記
第1および第2のポンプへ駆動信号を送出する制御部と
を備え、該駆動信号で前記第1および第2のポンプの送
液流量を制御することを特徴とする血中成分除去装置。
(1) A first pump that sends blood collected from a donor; the inside is partitioned into an inner chamber and an outer chamber by a membrane, and when the blood is led into the inner chamber, it is separated into plasma and blood cells. a plasma separator, a second pump that pumps the plasma in the outer chamber, and a selective remover that is filled with an adsorbent and selectively removes harmful components from the plasma when the plasma is introduced. ,
A first pressure gauge that detects the upstream pressure P_1 of the first pump, a second pressure gauge that detects the inlet pressure P_2 of the plasma separator, and a third pressure gauge that detects the pressure P_3 of blood returned to the donor. Pressure gauge and inlet side pressure P_ of the selective remover
A fourth pressure gauge detects the pressure P_5 in the outer chamber of the plasma separator, and a fifth pressure gauge detects the pressure P_5 in the outer chamber of the plasma separator. A blood component removal device comprising: a control section that sends a drive signal to the first and second pumps; and the drive signal controls the flow rate of liquid delivered by the first and second pumps.
(2)前記上流側圧力P_1の低下に対応させて前記第
1ポンプの送液流量を低下させると共に、前記入口側圧
力P_2と返血圧力P_3との差が一定圧力値C_1を
超えず前記返血圧力P_3が一定圧力値C_2を超えな
いように前記第1ポンプの送液流量を制御する特許請求
範囲第(1)項記載の血中成分除去装置。
(2) In response to the decrease in the upstream pressure P_1, the liquid delivery flow rate of the first pump is reduced, and the difference between the inlet pressure P_2 and the return pressure P_3 does not exceed a constant pressure value C_1. The blood component removal device according to claim 1, wherein the fluid flow rate of the first pump is controlled so that blood pressure P_3 does not exceed a constant pressure value C_2.
(3)前記入口側圧力P_2、返血圧力P_3、および
外室内圧力P_5に基ずく((P_2+P_3)/2−
P_5)の値が一定圧力値C_3を超えず、前記入力側
圧力P_4と返血圧力P_3との差が一定圧力値C_4
を超えないように、前記第2ポンプの送液流量を制御す
る特許請求範囲第(1)項若しくは第(2)項記載の血
中成分除去装置。
(3) Based on the inlet side pressure P_2, return pressure P_3, and outer chamber pressure P_5 ((P_2+P_3)/2−
P_5) does not exceed the constant pressure value C_3, and the difference between the input side pressure P_4 and the return pressure P_3 is the constant pressure value C_4.
The blood component removal device according to claim 1 or 2, wherein the flow rate of liquid sent by the second pump is controlled so that the flow rate does not exceed .
JP61124454A 1986-05-29 1986-05-29 Blood component removal device Expired - Lifetime JPH0657255B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP61124454A JPH0657255B2 (en) 1986-05-29 1986-05-29 Blood component removal device

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP61124454A JPH0657255B2 (en) 1986-05-29 1986-05-29 Blood component removal device

Publications (2)

Publication Number Publication Date
JPS62281956A true JPS62281956A (en) 1987-12-07
JPH0657255B2 JPH0657255B2 (en) 1994-08-03

Family

ID=14885919

Family Applications (1)

Application Number Title Priority Date Filing Date
JP61124454A Expired - Lifetime JPH0657255B2 (en) 1986-05-29 1986-05-29 Blood component removal device

Country Status (1)

Country Link
JP (1) JPH0657255B2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010058583A1 (en) * 2008-11-19 2010-05-27 旭化成クラレメディカル株式会社 Plasma purifying device and method for controlling blood purifying device

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5072494A (en) * 1973-09-07 1975-06-16
JPS5287196U (en) * 1975-12-25 1977-06-29
JPS59141952A (en) * 1983-02-02 1984-08-14 テルモ株式会社 Membrane type serum separator
JPS60227766A (en) * 1984-04-27 1985-11-13 横河電機株式会社 Artificial dialytic apparatus

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5072494A (en) * 1973-09-07 1975-06-16
JPS5287196U (en) * 1975-12-25 1977-06-29
JPS59141952A (en) * 1983-02-02 1984-08-14 テルモ株式会社 Membrane type serum separator
JPS60227766A (en) * 1984-04-27 1985-11-13 横河電機株式会社 Artificial dialytic apparatus

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010058583A1 (en) * 2008-11-19 2010-05-27 旭化成クラレメディカル株式会社 Plasma purifying device and method for controlling blood purifying device
JP5385917B2 (en) * 2008-11-19 2014-01-08 旭化成メディカル株式会社 Plasma purification apparatus and blood purification apparatus control method
US8758603B2 (en) 2008-11-19 2014-06-24 Asahi Kasei Medical Co., Ltd. Plasma purifying device and method of controlling plasma purifying device

Also Published As

Publication number Publication date
JPH0657255B2 (en) 1994-08-03

Similar Documents

Publication Publication Date Title
US4919817A (en) Blood cell washing systems and methods
JPS583705B2 (en) Double filtration plasma exchange device
EP0156496B1 (en) Apparatus for the treatment of plasma
EP0128683A2 (en) Single needle blood fractionation system having adjustable recirculation through filter
EP0240101A2 (en) Extracorporeal circulation apparatus
KR19980024552A (en) Method and apparatus for treating blood
JPS62281956A (en) Blood component removing apparatus
JPS62142567A (en) Double filtering type blood treatment apparatus
JPS6040303B2 (en) Double filtration plasma exchanger
JPH059008Y2 (en)
JPH0244759Y2 (en)
JPS644790B2 (en)
JP3242470B2 (en) Method for collecting residual liquid in the filter
JPH07265415A (en) Double filtering type blood treatment device
JPH0244760Y2 (en)
JPS6040302B2 (en) Double filtration plasma exchanger
JPH07265416A (en) Controller for blood pump
JPH01104272A (en) Blood treatment apparatus
JPS6327024B2 (en)
JPS6226072A (en) Blood treatment apparatus
JPH0446756Y2 (en)
JPS6154421B2 (en)
JPH0225407Y2 (en)
JPH1080478A (en) Plasma treatment by double filtration and plasma treatment apparatus
JPS61191366A (en) Serum treatment apparatus